Developers’ claims that eye-exercise apps such as SniperSight can help alleviate users’ astigmatism, near-sightedness, farsightedness, eye strain and age-related deterioration have been dismissed by a US ophthalmologist.
Investment directed into primary eyecare can potentially deliver £98m (NZ$210.8m) per year in net benefits for the National Health Service (NHS) in England, with benefits expected to be similar in other UK nations. This would help the UK government fulfil its objectives set out in the Darzi review t
A Christchurch-based ophthalmologist’s collection of popular articles for general practitioners (GPs) on how to diagnose and treat common eye problems has been revised and is now freely available online at gpeyes.co.nz
In a breakthrough for diagnosing cerebral visual impairment (CVI), Dr Nicola McDowell, a senior lecturer at Massey University, has developed a specialised tool, the Austin Assessment app.
Scientists at Nanyang Technological University Singapore (NTU Singapore) have developed rice-grain-sized soft robots that can transport up to four different drugs and release them in reprogrammable orders and doses.
A recent review found no irreversible visual function loss or ocular structural damage in individuals undergoing repeated low-level red-light (RLRL) therapy for myopia. Analysing 20 studies (i
A small US trial of a sustained-release intravitreous implant found geographic atrophy (GA) lesion growth was two-thirds less in treated eyes compared to controls over three months. Inflammasom
US researchers found patients with thyroid eye disease receiving teprotumumab (Tepezza) were 24 times more likely to suffer hearing-related impairments. Writing in Ophthalmic Plastic and Reconstruct
Artificial intelligence (AI) is now a part of our daily lives – it's not just about predicting which movie you'll binge next, finding the fastest route home, or powering tools like ChatGPT. In our AI-driven world, where machine learning and algorithms have become familiar conveniences, there is a le
The inaugural Nelson event celebrating all things running, The Spectacle, was hailed a resounding success with 1,500 competitors and crowds lining the streets on a scorching hot summer’s day in December.
The authors of a study of low-dose atropine to treat myopia in European children said the results favour 0.05% over 0.01% nightly eye-drop use, despite more adverse events in the former group.
Heidelberg Engineering has announced the epithelial thickness module for its anterior segment imaging platform Anterion has received FDA clearance.
